Pharma IQ | 06/14/2010
Ensuring eCTD readiness is now critical for gaining first time market approval. Dr. Klaus Menges from the Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, Bfarm joins Pharma IQ to discuss strategies for successful eCTD lifecycle management.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More